title: Nefazodone in diabetic neuropathy: response and biology.
authors.forename: P J
authors.initials: PJ
authors.lastname: Goodnick
authors.forename: K
authors.initials: K
authors.lastname: Breakstone
authors.forename: A
authors.initials: A
authors.lastname: Kumar
authors.forename: B
authors.initials: B
authors.lastname: Freund
authors.forename: C L
authors.initials: CL
authors.lastname: DeVane
mesh_terms: D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy; D003929:Diabetic Neuropathies / Q000097:blood / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D010879:Piperazines; D012701:Serotonin / Q000097:blood; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D000700:Analgesics; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D010879:Piperazines; D012701:Serotonin; D014230:Triazoles; C051752:nefazodone